Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024

Core Viewpoint - Affimed N.V. is set to release its second quarter 2024 results and corporate update on September 5, 2024, highlighting its ongoing commitment to immuno-oncology and cancer treatment [1]. Company Overview - Affimed N.V. is a clinical-stage immuno-oncology company focused on harnessing the innate immune system to combat cancer [3]. - The company develops innate cell engagers (ICE®) that target and kill various hematologic and solid tumors, utilizing its proprietary ROCK® platform to create customized molecules [3]. - Affimed is headquartered in Mannheim, Germany, and is led by a team of experienced biotechnology and pharmaceutical professionals [3]. Conference Call Details - The conference call will take place at 8:30 a.m. EDT / 14:30 CET and will be accessible via phone and webcast [1]. - Participants are encouraged to join the call 15 minutes early to avoid delays, and a replay will be available for 30 days post-call [2].